Amniocentesis Needle Market Analysis

Amniocentesis Needle Market Analysis

To get key market trends

  Download Free Sample

Based on product type, the market is segmented into 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. The amniocentesis needle type 100 to 150 mm is estimated to account for USD 94.6 million in 2023.
 

• Amniocentesis needles play a crucial role by employing suitable lengths of needle, thus minimizing the likelihood of procedural complications like tissue damage or insufficient sample collection.
   
• Furthermore, needles in the range of 100 to 150 mm strike a balance between being long enough to reach the amniotic sac safely and short enough to minimize the risk of complications such as uterine perforation.
   
• Moreover, the length of these needles allows for efficient collection of an adequate volume of amniotic fluid, ensuring accurate diagnostic testing without the need for multiple attempts.
   

The amniocentesis needle market by procedure is categorized into amniocentesis procedures, amnioreduction procedures, fetal blood transfusions, amnioinfusion procedures, and cordocentesis procedures. The amniocentesis procedures accounted for around USD 61.6 million revenue size in 2023.
 

• Amniocentesis facilitates the retrieval of amniotic fluid, rich in fetal cells and DNA, enabling precise assessment of the fetus's health and genetic composition, thereby facilitating the accurate diagnosis of a diverse array of genetic disorders and chromosomal abnormalities.
   
• Furthermore, by detecting genetic conditions such as down syndrome, cystic fibrosis, and neural tube defects early in pregnancy, amniocentesis enables expectant parents to make informed decisions about their pregnancy and potential medical interventions.
   
• Moreover, the amniocentesis procedure provides significant advantages in terms of accurate prenatal diagnosis, early detection and intervention, personalized risk assessment, reduction of uncertainty, improved prenatal care.
   

North America amniocentesis needle market accounted for USD 71.8 million revenue in 2023 and is predicted to witness substantial market growth.
 

• The large market share is correlated to a sophisticated healthcare systems with access to advanced medical technologies, facilitating widespread availability and utilization of amniocentesis procedures and related equipment like needles.
   
• The trend of delaying childbirth and an increase in maternal age contribute to a higher risk of chromosomal abnormalities in fetuses. Older mothers are more likely to undergo prenatal screening, including amniocentesis, to assess fetal health, leading to increased demand for amniocentesis needles.